BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37119644)

  • 1. Variation in adults' use of flavored tobacco products by sales restrictions in California jurisdictions.
    Timberlake DS; Aviles J; Payán DD
    Int J Drug Policy; 2023 Jun; 116():104041. PubMed ID: 37119644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are California's Local Flavored Tobacco Sales Restrictions Effective in Reducing the Retail Availability of Flavored Tobacco Products? A Multicomponent Evaluation.
    Andersen-Rodgers E; Zhang X; Vuong TD; Hendrix L; Edora C; Williams RJ; Groves L; Roeseler A; Rogers T; Voelker DH; Schleicher NC; Johnson TO; Henriksen L
    Eval Rev; 2021; 45(3-4):134-165. PubMed ID: 34693773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavored Tobacco Sales Restrictions and Teen E-cigarette Use: Quasi-experimental Evidence From California.
    Dove MS; Gee K; Tong EK
    Nicotine Tob Res; 2023 Jan; 25(1):127-134. PubMed ID: 35983929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Impact of Strong and Weak California Flavored Tobacco Sales Restriction Policies on the Tobacco Retail Environment.
    Welwean RA; Andersen-Rodgers E; Akintunde A; Zhang X
    Am J Health Promot; 2022 May; 36(4):687-696. PubMed ID: 35105227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the Comprehensiveness of Amended Flavored Tobacco Product Sales Restrictions.
    Donovan EM; Azadi M; Akbar M; Schillo BA
    J Public Health Manag Pract; 2023 Sep-Oct 01; 29(5):646-653. PubMed ID: 37071073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Local Flavored Tobacco Sales Restrictions on Policy-Related Attitudes and Tobacco Product Access.
    Feld AL; Rogers T; Gaber J; Pikowski J; Farrelly MC; Henriksen L; Johnson TO; Halpern-Felsher B; Andersen-Rodgers E; Zhang X
    Health Educ Behav; 2022 Jun; 49(3):468-477. PubMed ID: 34399591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographics, Tobacco Use, and Tobacco Control Measures of California Cities With Flavored Tobacco Sales Restrictions.
    Dove MS; Zheng S; Pakdaman S; Chen-Sankey J
    Health Promot Pract; 2024 May; 25(3):455-459. PubMed ID: 36416061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Statewide Restrictions on Flavored e-Cigarette Sales in the US From 2014 to 2020.
    Ali FRM; Vallone D; Seaman EL; Cordova J; Diaz MC; Tynan MA; Trivers KF; King BA
    JAMA Netw Open; 2022 Feb; 5(2):e2147813. PubMed ID: 35142832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of two state-level approaches to restricting the sale of flavored tobacco products.
    Satchell T; Diaz MC; Stephens D; Bertrand A; Schillo BA; Whitsel LP
    BMC Public Health; 2022 Sep; 22(1):1799. PubMed ID: 36138373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Qualitative Review of Studies Evaluating the Impact of Local US Laws Restricting the Sale of Flavored and Menthol Tobacco Products.
    Rogers T; Brown EM; Siegel-Reamer L; Rahman B; Feld AL; Patel M; Vallone D; Schillo BA
    Nicotine Tob Res; 2022 Mar; 24(4):433-443. PubMed ID: 34525207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Sales of Vaping Products and Cigarettes Associated With the New York State Flavored Vaping Product Sales Restriction.
    Brown EM; Rogers T; Spinks JG; Gammon D; Nonnemaker J; Farrelly MC
    Nicotine Tob Res; 2024 Jan; 26(2):135-141. PubMed ID: 37659102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavored Tobacco Product Use and Its Association With Indicators of Tobacco Dependence Among US Adults, 2014-2015.
    Odani S; Armour B; Agaku IT
    Nicotine Tob Res; 2020 May; 22(6):1004-1015. PubMed ID: 31180498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavored Tobacco Sales Restrictions and Youth E-cigarette Behavior: Impact by Tobacco Retailer Density in Diverse Communities in California.
    Dove MS; Gee KA; Tong EK
    Nicotine Tob Res; 2024 May; 26(Supplement_2):S65-S72. PubMed ID: 38817027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of State and Local Flavored Cigar Sales Restrictions, on Retail Sales of Large Cigars, Cigarillos, and Little Cigars in Massachusetts, California, Illinois, and New York.
    Diaz MC; Yoon SN; Donovan E; Akbar M; Schillo BA
    Nicotine Tob Res; 2024 Jan; 26(2):169-176. PubMed ID: 37453140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavored Tobacco Sales Restrictions Reduce Tobacco Product Availability and Retailer Advertising.
    Holmes LM; Lempert LK; Ling PM
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactions to Sales Restrictions on Flavored Vape Products or All Vape Products Among Young Adults in the United States.
    Posner H; Romm KF; Henriksen L; Bernat D; Berg CJ
    Nicotine Tob Res; 2022 Feb; 24(3):333-341. PubMed ID: 34331447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding local sales restrictions on flavoured tobacco products to include menthol: retail sales changes in two Minnesota cities.
    Olson LT; Gammon DG; Rogers T; Brown EM; Nonnemaker JM; Spinks JG; Ross A; Xu X; Moze J; Matter CM; D'Silva J
    Tob Control; 2024 Feb; 33(2):178-185. PubMed ID: 35902225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of statewide restrictions on e-cigarette nicotine strength-United States, 2017-2022.
    Ali FRM; Schillo B; Crane E; Seaman EL; King BA
    Addiction; 2023 Sep; 118(9):1701-1709. PubMed ID: 37039371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cigarette Unit Sales by Product and Flavor Type, and Top-Selling Brands, United States, 2020-2022.
    Ali FRM; Seidenberg AB; Crane E; Seaman E; Tynan MA; Marynak K
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(25):672-677. PubMed ID: 37347717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Unit Sales of Flavored and Menthol Electronic Cigarettes in the United States, 2012-2016.
    Kuiper NM; Loomis BR; Falvey KT; Gammon DG; King BA; Wang TW; Rogers T
    Prev Chronic Dis; 2018 Aug; 15():E105. PubMed ID: 30148426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.